Lazard Asset Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Lazard Asset Management’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,518	Closed	-$298K	–	2477
2024 Q1	$298K	Buy	7,518 +2,110	+39%	+$62.3K	﹤0.01%	1181
2023 Q4	$103K	Buy	+5,408	New	+$75.1K	﹤0.01%	1648
2022 Q3	–	Sell	-4,617	Closed	-$39K	–	2599
2022 Q2	$39K	Buy	+4,617	New	+$39.8K	﹤0.01%	1920

Lazard Asset Management's ALPN Position: Q2 2024 in Review

Lazard Asset Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 7,518 shares — an estimated $298K sold.

Lazard Asset Management first reported a position in ALPN in Q2 2022 and held it in 3 quarters. The position peaked at $298K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Lazard Asset Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Lazard Asset Management sold 7,518 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $298K.
Lazard Asset Management first reported a position in Alpine Immune Sciences Inc in Q2 2022 and held it in 3 quarters.
Lazard Asset Management's Alpine Immune Sciences Inc position peaked at $298K in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Lazard Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.